Article

Nitin Dua and Leyla Karakas

Private equity-backed companies contributed more than $2 trillion to the US gross domestic product in 2024, and over the past 20 years, assets managed by private equity have increased more than 15-fold. With the growth in investments, private equity now accounts for a substantial share of revenue in healthcare markets. This growing role has prompted attention from policymakers regarding market competition, price increases, and the effects on the quality of and access to care. At the same time, the economic evidence regarding the effects of private equity ownership and growth remains mixed. In “Private Equity in Healthcare: Trends, Evidence, and State Antitrust Enforcement,” authors Nitin Dua and Leyla Karakas examine the state of private equity and consolidation in healthcare, the issues regulators and policymakers are focusing on, and the evolving enforcement landscape.